Showing results (111-120 of 286) with videos related to
Sort By:
Pageof 29
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2004
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomasVassil Kaimaktchiev, Luigi Terracciano, Luigi Tornillo, et al.Cancer Research|October 3, 2007
Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumorsKatherine A Janeway, Bernadette Liegl, Amy Harlow, et al.The American Journal of Surgical Pathology|June 30, 2004
KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implicationsFabiola Medeiros, Christopher L Corless, Anette Duensing, et al.Scientific Reports|October 6, 2020
Diurnal stability of cell-free DNA and cell-free RNA in human plasma samplesJosiah T Wagner, Hyun Ji Kim, Katie C Johnson-Camacho, et al.Nature Communications|December 16, 2021
Epigenetic loss of heterogeneity from low to high grade localized prostate tumoursSebnem Ece Eksi, Alex Chitsazan, Zeynep Sayar, et al.Journal of Medical Genetics|January 9, 2007
Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1Douglas R Stewart, Christopher L Corless, Brian P Rubin, et al.The American Journal of Pathology|December 26, 2003
KIT mutations are common in testicular seminomasKathleen Kemmer, Christopher L Corless, Jonathan A Fletcher, et al.The American Journal of Surgical Pathology|May 6, 2010
Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmationKevin B Long, James E Butrynski, Seth D Blank, et al.NPJ Precision Oncology|October 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomyTomasz M Beer, Anne Myrthue, Mark Garzotto, et al.Pageof 29